Analysts foresee less revenue Biogen

Tomorrow Biogen will publish its past quarters results. Over the current book year the company from Cambridge could achieve a revenue around 10.57 billion USD (consensus estimates). This is quite lower than 2020's revenue of 13.44 billion USD.

Historical revenues and results Biogen plus estimates 2020

The analysts expect for 2021 a net profit of 2.78 billion USD. For this year most of the analysts expect a profit per share of 18.46 USD. So the price/earnings-ratio equals 14.64.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals a good 1.97 percent.

Biogen 's market capitalization is based on the number of outstanding shares around 47.09 billion USD. The Biogen stock was the past 12 months quite volatile. Since last April the stock is 21 percent lower. This year the stock price moved between 223 and 364 dollar.

Historical stock prices Biogen from 2007 till 2021

On Friday the stock closed at 270.31 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.